title: Artemisinin-based combination therapy (ACT) versus atovaquone-proguanil: do not choose between but, rather, combine them.
authors.affiliation: The Chaim Sheba Medical Center, The Center for Geographic Medicine, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel;
authors.forename: Eli
authors.initials: E
authors.lastname: Schwartz
authors.affiliation: The Infectious Diseases Unit, Shaare-Zedek Medical Center, Jerusalem, Israel.
authors.forename: Tamar
authors.initials: T
authors.lastname: Lachish
mesh_terms: D000655:Amodiaquine / Q000627:therapeutic use*; D000962:Antimalarials / Q000627:therapeutic use*; D037621:Artemisinins / Q000627:therapeutic use*; D053626:Atovaquone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy*; D008297:Male; D002727:Proguanil / Q000627:therapeutic use*
chemical_list: D000962:Antimalarials; D037621:Artemisinins; D000655:Amodiaquine; D002727:Proguanil; D053626:Atovaquone